<SEC-DOCUMENT>0001060955-25-000004.txt : 20250114
<SEC-HEADER>0001060955-25-000004.hdr.sgml : 20250114
<ACCEPTANCE-DATETIME>20250114080420
ACCESSION NUMBER:		0001060955-25-000004
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20250114
FILED AS OF DATE:		20250114
DATE AS OF CHANGE:		20250114

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ICON PLC
		CENTRAL INDEX KEY:			0001060955
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				981067160

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-08704
		FILM NUMBER:		25527800

	BUSINESS ADDRESS:	
		STREET 1:		SOUTH COUNTY BUSINESS PARK
		STREET 2:		LEOPARDSTOWN
		CITY:			DUBLIN 18
		STATE:			L2
		ZIP:			00000
		BUSINESS PHONE:		00 353 1 291 2000

	MAIL ADDRESS:	
		STREET 1:		SOUTH COUNTY BUSINESS PARK
		STREET 2:		LEOPARDSTOWN
		CITY:			DUBLIN 18
		STATE:			L2
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ICON PLC  /ADR/
		DATE OF NAME CHANGE:	20010213
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>a6kofpr-financialguidance.htm
<DESCRIPTION>6-K
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i4e7aada366c04e4ba3c7f81ea80d75a0_1"></div><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;FORM 6-K</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Washington, D.C. 20549</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Foreign Private Issuer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Rule 13a-16 under</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">he Securities Exchange Act of 1934</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the month of January 2025</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICON plc</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Translation of registrant's name into English)</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">333-08704</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Commission file number)</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">South County Business Park, Leopardstown, Dublin 18, Ireland</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices)</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.836%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Form 20-F __</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">X</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form 40-F ______</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160; </font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes______</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No___</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">X</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___</font></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160; </font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes______</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No___</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">X</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___</font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160; </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT LIST</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.978%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.802%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.804%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160; </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160; </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="a2025financialguidancepres.htm" style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">99.1</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160; </font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="a2025financialguidancepres.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ICON plc Press Release issued January 14, 2025 - ICON Issues Financial Guidance for Full Year 2025</a></font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160; </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160; </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ICON plc</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Nigel Clerkin</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; January 14, 2025</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nigel Clerkin</font></div><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a2025financialguidancepres.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i5481f35b39314811acabe9a5271ee808_1"></div><div style="background-color:#ffffff"><div style="min-height:42.48pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div><div style="text-align:center"><img alt="image_0.jpg" src="image_0.jpg" style="height:41px;margin-bottom:5pt;vertical-align:text-bottom;width:152px"></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICON Issues Financial Guidance for Full Year 2025</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Highlights </font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Full year 2025 revenue guidance in the range of $8,050 - $8,650 million&#59; midpoint of $8,350 million representing growth of approximately 1% over full year 2024 revenue guidance midpoint. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Full year 2025 adjusted earnings per share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">*</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> guidance in the range of $13.00 - $15.00&#59; midpoint of $14.00, flat over full year 2024 adjusted earnings per share guidance midpoint. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">With respect to full year 2024, the company reaffirmed its current guidance of revenue in the range of $8,260 - $8,300 million and adjusted earnings per share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">*</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the range of $13.90 - $14.10.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In quarter four 2024, the company repurchased a total of $400 million worth of stock at an average price of $217.  For the full year 2024, the company repurchased a total of $500 million worth of stock.  </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font><br></font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Dublin, Ireland, January 14, 2025 &#8211; ICON plc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%"> (NASDAQ&#58; ICLR),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> a world-leading clinical research organization powered by healthcare intelligence, today announced its financial guidance for the year ending December 31, 2025.  For the full year 2025, revenue is expected to be in the range of $8,050 - $8,650 million, representing growth of approximately 1% at the midpoint and adjusted earnings per share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:133%;position:relative;top:-3.5pt;vertical-align:baseline">*</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> is expected to be in the range of $13.00 - $15.00, which is flat over the expected full year 2024 adjusted earnings per share guidance midpoint.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Full year 2025 financial guidance excludes any potential share repurchase or additional M&#38;A activity.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CEO Dr. Steve Cutler commented, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;ICON continues to navigate dynamic clinical development market conditions, as trial activity has been impacted by cautious spending from biopharma customers, in both the biotech and large pharma businesses.  Our outlook for this year reflects an expected transition period which includes a headwind from our top two customers on a combined basis, coupled with an inconsistent recovery in biotech.  This is being partially offset by growth in strategic partnerships that are expected to contribute to our results as we progress through the year.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We will continue to manage the business appropriately based on the environment through leveraging technology, automation and other cost management initiatives.  While recent market trends present challenges to normalized growth in the near-term, ICON&#8217;s differentiated offering is delivering value for our customers around the world.  Our superior outcomes are driving additional opportunities to further solidify our position as a strategic partner to an increasing number of well-positioned customers. We saw evidence of this in quarter four, as our trailing twelve month book to bill result was in-line with our expectation of 1.2 times.&#8221; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to full year 2024, the company reaffirmed its current guidance of revenue in the range of $8,260 - $8,300 million and adjusted earnings per share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">*</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the range of $13.90 - $14.10.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In quarter four 2024, the company repurchased a total of $400 million worth of stock at an average price of $217.  For the full year 2024, the company repurchased a total of $500 million worth of stock, leaving $250 million remaining on the current authorization from the Board of Directors.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Information</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">In addition to the financial measures prepared in accordance with generally accepted accounting principles (GAAP), this press release contains certain non-GAAP financial measures, including adjusted EBITDA, adjusted net income and adjusted diluted earnings per share. Adjusted EBITDA, adjusted net income and adjusted diluted earnings per </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:42.48pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">share exclude amortization, stock compensation, foreign exchange gains and losses, restructuring and transaction-related &#47; integration-related adjustments.  While non-GAAP financial measures are not superior to or a substitute for the comparable GAAP measures, ICON believes certain non-GAAP information is useful to investors for historical comparison purposes.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This press release contains forward-looking statements, including statements about our financial guidance. These statements are based on management's current expectations and information currently available, including current economic and industry conditions.&#160; These statements are not guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release.&#160; The forward-looking statements are subject to future events, risks, uncertainties and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new offices and offering of new services, the integration of new business mergers and acquisitions, as well as other economic and global market conditions and other risks and uncertainties detailed from time to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions. The word &#34;expected&#34; and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by ICON, including its Form 20-F, F-1, F-4, S-8, F-3 and certain other reports, which are available on the SEC's website at www.sec.gov. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">* Our full year 2024 and 2025 guidance adjusted earnings per share measures are provided on a non-GAAP basis because the company is unable to predict with a reasonable degree of certainty certain items contained in the GAAP measures without unreasonable efforts. For the same reasons, the company is unable to address the probable significance of the unavailable information.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">ICON plc is a world-leading healthcare intelligence and clinical research organization. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 42,250 employees in 106 locations in 55 countries as at September&#160;30, 2024. For further information about ICON, visit&#58; www.iconplc.com.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Source&#58; ICON plc</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contact&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investor Relations +1 888 381 7923</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nigel Clerkin Chief Financial Officer + 353 1 291 2000</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kate Haven Vice President Investor Relations +1 888 381 7923 </font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICON&#47;ICLR-F</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_0.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" !? 5X# 2(  A$! Q$!_\0
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M5.!N;G<SX!9B3P, ?=W_  <$?M27UA9>&_V2/"^J;([Z-=<\5+#(V7C5RMI
MV#@J7224J<G,<+<<$_ES7U&3814Z7MI+5[>2_P""?R]XR<6UL?FO]C4)?NJ-
MG.WVIM7U\H)VM_,W?96****]P_$@K]+?^">G_!%/X6_&;X$Z-\=?VD?$>N-+
MXEM?MFCZ#HEY'!'#9M_JI)7*,S.X^<*I4*K*#DY _-*OZ(/V!?\ DR+X2_\
M9/-)_P#22.O(SC$5L/1C[-VNS]:\(>'\IS[.ZWU^DJD:<+J+VNY)7:ZV6R>F
MNVQ^5_\ P55_X)>^'?V(=.T;XI_"?Q9J&H>$]:U(Z=+::TZ/=6-V8WE10Z(J
MR1LD<F,@,NS!+9R/B^OV._X.$_\ DR[PS_V4ZR_]-VHU^.-;Y76J5\(I3=W=
MH\7Q.R;+\BXLJ8?!0Y*;C&7*MDVM;7Z7UMTZ:!1117H'Y^?27_!,W]O#7_V)
M_C?#/K%W-/X'\0S1VWBS31EA&N<)>1KG_619R>NY-R]2I7])/^"L?_!0RU_9
M=^!=EX:^$'B2WF\9>.K-FT*^LY1(MCI[#Y[]64X).0L1Z%B6&1&0?Q)K4\4>
M-O%WC9["3Q=XCO-2;2]+ATW36O)C)]FM(01% F>B("0%Z 5Y^(R^C7Q,:KZ;
MKOV/T'(O$/.,BX:Q&4TF_?\ X<KZT[_';U6W\LKO=F;//-<S/<W,S222,6DD
MD8LS,3DDD]3FFT5UGP-^"?Q#_:)^*>C_  >^%VC->ZQK-R(H%.1'"O5YI& .
MR-%!9FQP!W.!7=*48QN]CX.C1K8JM&E2BY2DTDEJVWHDEU;9B^$/!WBWX@>(
M[3P?X&\,WVL:M?2B.STW3;5IIIF]%102?\*^V/@/_P $#?VJ/B/I]MKGQ?\
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M_:GC76_%[>&O!NBW0M)M2BL_.GO;K:',$*DA1M5D9G8G'F( K9.WY3K]J/\
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ME_E7SN?_ /+OY_H?T/X"?%F/_<'_ -RGP%_P</\ _)L/@G_L?%_](KFO+O\
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M:'%;V_C3P[YEWX3OYL*&<C]Y:.W:.4*HS_"ZHW0$'R\1F=+#XJ-)[=7V[?\
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M^R^MG>VE_+Z_IWL3_H4/_7)?Y5_,17WG#_P<)_M>P1+"OPH^&^%4 9TW4/\
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>SM8A'%!$BA41%  50H  '  JU117@'[Y&*C&R/_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
